Abstract:
Case report:
A 22 years young man presented to surgery OPD with the complaints of gradually increasing painless abdominal lump for 3 years.
His bowel and bladder habit was normal. He had no history of fever, anorexia, weight loss, constipation, diarrhoea, abdominal pain or abdominal distension. Physical examination revealed the presence of an 8 x 10 cm welldefined nontender mass with a smooth surface in the left abdomen. On percussion it was dull over the mass. His vital parameters were normal. There was no other palpable lymph nodes.
An abdominal ultra-sound & computed tomography (CT) scan of his abdomen revealed minimally enhancing soft tissue density lesion in the left para aortic region measuring about 71mm x 42 mm in size, consistant with enlarged lymph node.
After taking written informed consent he was underwent exploratory laparotomy. After opening of the abdomen, a lump measuring about 8 cm x 5 cm was found in the mesentery. The whole lump was dissected out and the gap in the mesentery was closed. No other lymphadenopathy was found. The specimen was sent for histopathology which revealed Castleman disease, plasma cell type. The patient completely recovered after surgery.
Discussion:
Castleman disease is a rare variety of benign hypertrophy of lymphoid tissue. It is regarded as a pre lymphomatous condition. The disease was first described in 1956 by Benjamin Cattleman,who identified a group of patients with solitary hyperplasic mediastinal lymph nodes with small germinal center 1 . Although the etiology of CD remains unclear, the pathogenesis is related to an abnormal immune response to viral infections or medication side effects that can cause similar changes in hyperplastic reactive lymph nodes 2 . The hepatitis B and Epstein-Barr viruses and HIV are the result of the immune perturbation that may be seen with CD 4 .
Some studies found that inflammatory cytokines were associated with the manifestation of a variety of symptoms accompanying CD, especially for plasma cell type or multicentric CD (MCD). There are 3 types of CD: hyaline vascular type, plasma cell type and mixed type [3] .Unicentric hyaline vascular CD is the most common histological form of the disease. However clinically, according to the involved range it can be divided into 2 types: MCD and local CD (LCD) 3 .
The clinical features of LCD are painless enlarged lymph nodes, usually localized in the mediastinum, cervical, axillary lymph nodes or abdomen; it may also occur in the muscles, larynx and lungs and orbits where no lymph nodes exist. Some patients experience fever, sweat, fatigue, anorexia and substantial weight loss. Routine blood tests usually reveal anaemia, raised ESR, thrombocytopenia and raised polyclonal gamma globulins. Identifying an immunophenotypically varied population of Blymphocytes with polyclonal surface and cytoplasmic immunoglobulin markers helps to confirm the diagnosis of Castleman's disease and differentiate it from lymphoma 5 . HIV testing should be undertaken. Herpes Virus (HHV 8/KSHV) has been isolated in almost all cases of HIV associated Kaposi's sarcoma MCD and some non HIV Kaposi's sarcoma MCD prompting tests for KSHV [6] . Histological examination of the biopsied lymph node is essential for the diagnosis. Histologically the main types are:
• The hyaline vascular type characterized by lymphoid follicular proliferation at different levels of maturity, often forming a layered or 'onionskin' pattern surrounding a hyalinised vessel at the center of the follicle. These vessels are often prominent and reactive. This is more commonly seen in the localized form of the disease.
• The plasma cell variant has sheets of mature plasma cells within the interfollicular tissues surrounding larger germinal centers and has significantly less vascularity.
• A third histological variant showing a mixed picture can also be seen in MCD.
Localized CD usually has a good prognosis and requires surgical excision of the enlarged lymph node with no further treatment. The patients generally remain asymptomatic thereafter. MCD however tends to have a variable prognosis with no documented treatment consensus. A variety of combination treatments have been tried with surgical excision, chemotherapy and steroids.
Conclusion:
The aim of the discussion is to revisit the rare clinicopathological diagnosis of Castleman disease, its treatment and prognosis. The unicentric variety is of good prognosis overall.
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